GGrantIndex
← Leaderboards

J Curtis Nickel

Queen'S University At Kingston

$5,497,993
Attributed
$5,497,993
Total exposure
5
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $749.9K · FY200518
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$5,497,993 · 5

By mechanism

U01$5,497,993 · 5

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Quality Of Life

Research focus

Quality Of LifeClinical ResearchClinical TrialsProstatitisSymptomsUnited States National Institutes Of HealthHuman Therapy EvaluationInterstitial CystitisHuman SubjectPrincipal InvestigatorBaseNickelUrologicCanadaAmitriptylineMalePainChronic PainEtiologyEpidemiologyEnrollmentDiagnosticChronic Pelvic PainChronic Prostatitis

Grant awards (29)

Expansion of the MAPP Research Network: Microbial and Biopsychosocial Contributio$236,048
U01 · FY2018 · DK · contact PI
Expansion of the MAPP Research Network: Microbial and Biopsychosocial Contributio$233,333
U01 · FY2017 · DK · contact PI
Expansion of the MAPP Research Network: Microbial and Biopsychosocial Contributio$233,407
U01 · FY2016 · DK · contact PI
Expansion of the MAPP Research Network: Microbial and Biopsychosocial Contributio$233,333
U01 · FY2015 · DK · contact PI
Expansion of the MAPP Research Network: Microbial and Biopsychosocial Contributio$233,333
U01 · FY2014 · DK · contact PI
Alternative Therapies for Benign Prostatic Hyperplasia (CAMUS)$72,450
U01 · FY2010 · DK · contact PI
Alternative Therapies for Benign Prostatic Hyperplasia$178,155
U01 · FY2009 · DK · contact PI
Alternative Therapies for Benign Prostatic Hyperplasia$55,041
U01 · FY2008 · DK · contact PI
Interstitial Cystitis Clinical Research Network (ICCRN)$237,045
U01 · FY2007 · DK · contact PI
Chronic Prostatitis Collaborative Research Network CPCRN$237,045
U01 · FY2007 · DK · contact PI
Chronic Prostatitis Collaborative Research Network CPCRN$125,000
U01 · FY2007 · DK · contact PI
Chronic Prostatitis Collaborative Research Network CPCRN$124,621
U01 · FY2007 · DK · contact PI
Chronic Prostatitis Collaborative Research Network CPCRN$259,125
U01 · FY2006 · DK · contact PI
Interstitial Cystitis Clinical Research Network (ICCRN)$244,125
U01 · FY2006 · DK · contact PI
Chronic Prostatitis Collaborative Research Network CPCRN$125,000
U01 · FY2006 · DK · contact PI
Chronic Prostatitis Collaborative Research Network CPCRN$121,692
U01 · FY2006 · DK · contact PI
Interstitial Cystitis Clinical Research Network (ICCRN)$250,000
U01 · FY2005 · DK
Chronic Prostatitis Collaborative Research Network CPCRN$250,000
U01 · FY2005 · DK
Chronic Prostatitis Collaborative Research Network CPCRN$125,000
U01 · FY2005 · DK
Alternative Therapies for Benign Prostatic Hyperplasia$258,771
U01 · FY2004 · DK
Interstitial Cystitis Clinical Research Network (ICCRN)$250,000
U01 · FY2004 · DK
Chronic Prostatitis Collaborative Research Network CPCRN$250,000
U01 · FY2004 · DK
Alternative Therapies for Benign Prostatic Hyperplasia$276,990
U01 · FY2003 · DK
Chronic Prostatitis Collaborative Research Network CPCRN$250,000
U01 · FY2003 · DK
Interstitial Cystitis Clinical Research Network (ICCRN)$81,216
U01 · FY2003 · DK
CHARACTERIZATION &TREATMENT OF CATEGORY III PROSTATITIS$55,418
U01 · FY2003 · DK
CHARACTERIZATION &TREATMENT OF CATEGORY III PROSTATITIS$168,371
U01 · FY2002 · DK
CHARACTERIZATION &TREATMENT OF CATEGORY III PROSTATITIS$164,100
U01 · FY2001 · DK
CHARACTERIZATION &TREATMENT OF CATEGORY III PROSTATITIS$169,374
U01 · FY2000 · DK